U.S. FDA Revokes ‘Voluntary Action Initiated’ Status For Aurobindo Pharma’s Hyderabad Unit
A man rides past an Aurobindo Pharma Ltd. production facility in Jadcherla, Telangana. (Photographer: Prashanth Vishwanathan/Bloomberg)

U.S. FDA Revokes ‘Voluntary Action Initiated’ Status For Aurobindo Pharma’s Hyderabad Unit

The U.S. drug regulator revoked the ‘Voluntary Action Initiated’ status issued to Aurobindo Pharma Ltd.’s plant in Hyderabad, days after indicating it might not pursue further regulatory action.The...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.